INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

IMPORTANCE OF THE FIELD: Novel approaches are needed for patients with small cell lung cancer (SCLC), as response after relapse is poor with standard therapies. p53 gene mutations often occur, resulting in tumoral protein overexpression and allowing for their recognition by p53-specific cytotoxic T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chiappori, Alberto A, Soliman, Hatem, Janssen, William E, Antonia, Scott J, Gabrilovich, Dmitry I
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3146364/
https://ncbi.nlm.nih.gov/pubmed/20420527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2010.484801
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars